Since 2013, the ITOMIC triple negative breast cancer trial has been on the leading edge of where cancer advances are going... equipping physicians and patients with personalized information about how to treat their cancer. To date, 31 patients have been enrolled in the trial, 28 of whom are South Sound CARE patients. The ITOMIC trial has opened up an avenue for this innovative approach for patients with an incurable form of breast cancer. The study is getting international attention in scientific articles... and now in the New York Times.
Related Articles
We take pride in every project we undertake, but there’s something uniquely rewarding about helping our customers launch or grow their businesses...
At Rush, our commitment to giving back to the communities in which we live and work remains stronger than ever. Over the past 12 months, we had the...
At The Rush Companies, we witness our team consistently "doing the right thing" each day. Through our "Caught Doing Something Right (CDSR) program,...